Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05812872
Other study ID # FDASU-RecIR092210
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date June 20, 2017
Est. completion date January 20, 2019

Study information

Verified date March 2023
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study was to compare the efficacy of using allograft, autogenous tooth graft, and beta-tricalcium phosphate for alveolar ridge preservation (ARP) by examining the alveolar ridge height and width at baseline and 3 months after the ARP both clinically and radiographically. The secondary objective was to evaluate the quality of the newly formed bone using histomorphometric analysis.


Description:

This randomized controlled clinical trial included thirty patients. ARP was performed using either Allograft (Allograft group n=10), Tooth graft (Toothgraft group n=10), and beta tri-calcium- phosphate (beta tri-calcium group n=10). Changes in alveolar ridge dimensions were evaluated clinically and radiographically using cone beam computed tomography at baseline and 3 months. Core bone biopsy samples were obtained 3 months post-extraction during implant placement for histomorphometric analysis.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date January 20, 2019
Est. primary completion date September 23, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: 1. seeking implant-based restorations after tooth extraction. 2. exhibited no evidence of any significant medical history, measured using Burket's Oral medicine health history questionnaire. 3. exhibited Type I and II sockets Exclusion Criteria: 1. nonsmokers. 2. Pregnant and breast-feeding females 3. patients with known contraindications to dental implant surgery (e.g., increased bleeding tendency, history of treatments such as radiotherapy,

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Toothgraft
Particulate dentin
Allograft
Mineralized corticocancellous allograft
Alloplast
Beta tri-calcuim phosphate

Locations

Country Name City State
Egypt Ain Shams University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Other Histological Masson trichrome special stain was used to detect the area percentage of immature collagen and mature collagen at magnification 20X. The immature collagen appeared blue in color while areas with mature collagen appeared reddish in color 3 months
Other Histomorphometric analysis Photomicrographs of 3 microscopic fields of each MT stained section, were captured at the original magnification of 20X using a digital camera(Canon EOS 650D) mounted on a light microscope(BX60,Olympus , Japan). The images were analyzed for obtaining the area percentage of mature and immature collagen of the newly formed bone using image J (1.41aNIH, USA)software 3 months
Primary Clinical assessment Measure bone height loss in millimeter at baseline and after 3 months was measured using periodontal probe from the stent margin to the alveolar ridge crest at six points. In addition, Bone width loss was calculated by measuring alveolar ridge width buccopalatally in millimeter using a caliper clamp. The measurement was done perpendicular to the tangent of the dental arch at the mid-point of the extraction site approximately 4mm apical to the level of the marginal gingiva of the adjacent teeth. 3 months
Primary Clinical assessment Bone width loss was calculated by measuring alveolar ridge width buccopalatally in millimeter using a caliper clamp. The measurement was done perpendicular to the tangent of the dental arch at the mid-point of the extraction site approximately 4mm apical to the level of the marginal gingiva of the adjacent teeth. 3 months
Secondary Radiographic assessment Measuring loss in bone height in millimeters between baseline and after 3 months. Loss in bone height was calculated by measuring the distance from the alveolar crest both buccally and palatally to a fixed anatomical landmark. In addition, 3 months
Secondary Radiographic assessment Loss in bone width was calculated by measuring distance from buccal alveolar crest to palatal alveolar crest in millimeter. 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05572242 - Leukocyte-platelet Rich Fibrin for Alveolar Ridge Preservation N/A
Recruiting NCT05005858 - Modified Ridge Splitting Technique Using Autogenous Bone Blocks (MRS) N/A
Completed NCT05781529 - Injectable Platelets Rich Fibrin Versus Hyaluronic Acid for Alveolar Ridge Preservation N/A
Recruiting NCT05426616 - Titanium Reinforced d-PTFE Membrane Versus Collagen Membrane For Guided Bone Regeneration N/A
Completed NCT06020092 - Histological Analysis of Osteogenic Potential of Biphasic Calcium Phosphate Phase 4
Recruiting NCT05610748 - Implant-supported Rehabilitation With SPAL Technique or Soft Tissue Augmentation Phase 4
Completed NCT04376320 - Comparison of Two Pre-prosthetic Surgical Techniques for Augmentation of Mandibular Vertical Ridge Defects N/A